Supplements should not be considered as a substitute for a varied and balanced diet and a healthy lifestyle
Thus, in perfect agreement with the recent ADA-EASD consensus report [6], we also encourage the adoption of GLP-1RA plus SGLT2i combination therapy in T2DM patients with established ASCVD (coronary artery disease, cerebrovascular disease, or peripheral arterial disease) or multiple risk factors for ASCVD (i.e., age 55 years, obesity, dyslipidemia, hypertension, current tobacco use, left ventricular hypertrophy, and/or proteinuria) whose HbA1c remains suboptimal despite initial treatment with only one of these agents
It is whether the side effects are manageable, temporary, and worth the benefit
It is more price effective for our customers to supply themselves from local pharmacies or online retailers
No se han identificado metabolitos activos definidos
Stage 3 - Treatment plan and prescription